Antibody-functionalized hybrid superparamagnetic nanoparticles

被引:43
作者
Arruebo, Manuel
Fernandez-Pacheco, Rodrigo
Velasco, Beatriz
Marquina, Clara
Arbiol, Jordi
Irusta, Silvia
Ibarra, M. Ricardo
Santamaria, Jesus
机构
[1] Univ Zaragoza, Nanosci Inst Aragon INA, E-50009 Zaragoza, Spain
[2] Univ Zaragoza, CSIC, Mat Sci Inst Aragon, E-50009 Zaragoza, Spain
[3] Univ Barcelona, TEM MAT, Serv Cientificotecn, E-08028 Barcelona, Spain
关键词
D O I
10.1002/adfm.200600560
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Superparamagnetic hybrid nanoparticles (ca. 80 nm) are obtained. They consist of an inner iron oxide core coated by a silica shell, which is in turn functionalized with amine or carboxyl groups and covalently coupled to a monoclonal antibody (anti-hCG; hCG = human chorionic gonadotropin). The prepared nanoparticles show a specific magnetic moment (per gram of iron) that is comparable to that measured for commercial superparamagnetic iron oxide preparations. The bioactivity of the antibody-conjugated magnetic nanoparticles is verified by a standard bioassay. These results indicate the potential of the hybrid nanoparticles prepared for use as enhanced contrast agents in magnetic resonance imaging applications.
引用
收藏
页码:1473 / 1479
页数:7
相关论文
共 34 条
[1]   Receptor-mediated endocytosis of iron-oxide particles provides efficient labeling of dendritic cells for in vivo MR imaging [J].
Ahrens, ET ;
Feili-Hariri, M ;
Xu, H ;
Genove, G ;
Morel, PA .
MAGNETIC RESONANCE IN MEDICINE, 2003, 49 (06) :1006-1013
[2]   Biofunctionalization of surfaces of nanostructured porous silicon [J].
Arroyo-Hernández, M ;
Martín-Palma, RJ ;
Pérez-Rigueiro, J ;
García-Ruiz, JP ;
García-Fierro, JL ;
Martínez-Duart, JM .
MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS, 2003, 23 (6-8) :697-701
[3]   Development of magnetic nanostructured silica-based materials as potential vectors for drug-delivery applications [J].
Arruebo, M ;
Galán, M ;
Navascués, N ;
Téllez, C ;
Marquina, C ;
Ibarra, MR ;
Santamaría, J .
CHEMISTRY OF MATERIALS, 2006, 18 (07) :1911-1919
[4]   MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles [J].
Artemov, D ;
Mori, N ;
Okollie, B ;
Bhujwalla, ZM .
MAGNETIC RESONANCE IN MEDICINE, 2003, 49 (03) :403-408
[5]  
Bangs laboratories Inc, 205 BANGS LAB INC
[6]   Fe-based nanoparticulate metallic alloys as contrast agents for magnetic resonance imaging [J].
Bomatí-Miguel, O ;
Morales, MP ;
Tartaj, P ;
Ruiz-Cabello, J ;
Bonville, P ;
Santos, M ;
Zhao, XQ ;
Veintemillas-Verdaguer, S .
BIOMATERIALS, 2005, 26 (28) :5695-5703
[7]   Cancer incidence and mortality in Europe, 2004 [J].
Boyle, P ;
Ferlay, J .
ANNALS OF ONCOLOGY, 2005, 16 (03) :481-488
[8]   Iron oxide MR contrast agents for molecular and cellular imaging [J].
Bulte, JWM ;
Kraitchman, DL .
NMR IN BIOMEDICINE, 2004, 17 (07) :484-499
[9]   Angiogenesis in cancer and other diseases [J].
Carmeliet, P ;
Jain, RK .
NATURE, 2000, 407 (6801) :249-257
[10]   Investigation of formation of silica-coated magnetite nanoparticles via sol-gel approach [J].
Deng, YH ;
Wang, CC ;
Hu, JH ;
Yang, WL ;
Fu, SK .
COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, 2005, 262 (1-3) :87-93